Vertex Pharmaceuticals (NASDAQ:VRTX)报告2024年第四季度每股收益为$3.50，低于分析师预测的$3.57，差异为1.96%。公司报告季度销售额为$29.12亿，高于分析师预测的$27.81亿，超出4.70%。相比去年同期的$25.18亿，这是一个15.66%的增幅。
以上内容来自Benzinga Earnings专栏，原文如下：
Vertex Pharmaceuticals (NASDAQ:VRTX) reported quarterly earnings of $3.50 per share which missed the analyst consensus estimate of $3.57 by 1.96 percent. The company reported quarterly sales of $2.912 billion which beat the analyst consensus estimate of $2.781 billion by 4.70 percent. This is a 15.66 percent increase over sales of $2.518 billion the same period last year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.